Michael Scolaro

Michael Scolaro

Nov 10, 2017

Group 6 Copy 250
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis

Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...

Synthesis of a Kidney Cancer Drug

We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...

From Minerals to Medicines: A New Technology for Heavy Metal Pollution Remediation

This is the first part of a multi-phase experiment in which I will prove that substances isolated from plant...

Backer Badge Funded